Peijian Peng
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Cancer Research
- Immunology
- Co-authors
- Shaodong HongWenfeng FangJianhua ZhanLi ZhangLin ZhongLin LiuTing ZhouSheng Jin
- Topics
- Lung Cancer Treatments and Mutations (14 papers)Head and Neck Cancer Studies (12 papers)Lung Cancer Research Studies (11 papers)
- Partner nations
- China
In The Last Decade
Peijian Peng
23 papers receiving 831 citations
Peers
Comparison fields: 5 of 67
- Oncology 558
- Pulmonary and Respiratory Medicine 385
- Molecular Biology 183
- Cancer Research 152
- Immunology 142
Countries citing papers authored by Peijian Peng
This map shows the geographic impact of Peijian Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peijian Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peijian Peng more than expected).
Fields of papers citing papers by Peijian Peng
This network shows the impact of papers produced by Peijian Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peijian Peng. The network helps show where Peijian Peng may publish in the future.
Co-authorship network of co-authors of Peijian Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Peijian Peng. A scholar is included among the top collaborators of Peijian Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peijian Peng. Peijian Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 23 | |
| 3 | 23 | |
| 4 | 12 | |
| 5 | 4 | |
| 6 | 23 | |
| 7 | 3 | |
| 8 | 6 | |
| 9 | 27 | |
| 10 | 16 | |
| 11 | 236 | |
| 12 | 27 | |
| 13 | 15 | |
| 14 | 59 | |
| 15 | 42 | |
| 16 | 11 | |
| 17 | 12 | |
| 18 | 34 | |
| 19 | 21 | |
| 20 | A randomized phase-II clinical control study on standard radiotherapy in combination with weekly oxaliplatin for treatment of loco-regional advanced nasopharyngeal carcinoma | 0 |
About Peijian Peng
Peijian Peng is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 834 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Head and Neck Cancer Studies (12 papers) and Lung Cancer Research Studies (11 papers). The work is most often cited by research in Otorhinolaryngology (123 citations), Oncology (558 citations) and Pulmonary and Respiratory Medicine (385 citations). Peijian Peng has collaborated with scholars based in China. Frequent co-authors include Shaodong Hong, Wenfeng Fang, Jianhua Zhan, Li Zhang, Lin Zhong, Lin Liu, Ting Zhou, Sheng Jin, Jiaxing Huang and Ying Chen. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.